Compare · CDXS vs DD
CDXS vs DD
Side-by-side comparison of Codexis Inc. (CDXS) and DuPont de Nemours Inc. (DD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDXS and DD operate in Major Chemicals (Industrials), so they compete in similar markets.
- DD is the larger of the two at $17.77B, about 119.3x CDXS ($148.9M).
- DD has been more active in the news (6 items in the past 4 weeks vs 3 for CDXS).
- DD has more recent analyst coverage (25 ratings vs 12 for CDXS).
- Company
- Codexis Inc.
- DuPont de Nemours Inc.
- Price
- $1.24-9.19%
- $130.53-0.77%
- Market cap
- $148.9M
- $17.77B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2010
- 2017
- News (4w)
- 3
- 6
- Recent ratings
- 12
- 25
Codexis Inc.
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
DuPont de Nemours Inc.
DuPont de Nemours, Inc. provides technology-based materials, ingredients, and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company's Electronics & Imaging segment supplies materials to manufacture photovoltaics and solar cells; materials and printing systems to the advanced printing industry; and materials and solutions for the fabrication of semiconductors and integrated circuits addressing front-end and back-end of the manufacturing process. This segment also provides semiconductor and advanced packaging materials; dielectric and metallization solutions for chip packaging; and silicones for light emitting diode packaging and semiconductor applications; permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, electroless, and electrolytic metallization solutions, as well as patterning solutions, and materials and metallization processes for metal finishing, decorative, and industrial applications. In addition, it offers various materials to manufacture rigid and flexible displays for liquid crystal displays, advanced-matrix organic light emitting diode, and quantum dot applications. The Transportation & Advanced Polymers segment provides engineering resins, adhesives, silicones, lubricants, and parts to engineers and designers in the transportation, electronics, healthcare, industrial, and consumer end-markets. Its Safety & Construction segment provides engineered products and integrated systems for worker safety, water purification and separation, aerospace, energy, medical packaging, and building materials. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. is based in Wilmington, Delaware.
Latest CDXS
- SEC Form 4 filed by Codexis Inc.
- SEC Form 4 filed by Codexis Inc.
- Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA
- Codexis to Participate in Cantor Global Healthcare Conference 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Codexis Inc.
- SEC Form 10-Q filed by Codexis Inc.
- Codexis Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- Codexis Reports Second Quarter 2026 Financial Results
- Codexis Appoints David Butler, PhD, to Strategic Advisory Board
- Codexis to Report Second Quarter 2026 Financial Results on August 11
Latest DD
- DuPont Announces Regular Quarterly Dividend on Common Stock
- Barclays initiated coverage on DuPont with a new price target
- DuPont downgraded by Analyst with a new price target
- DuPont Schedules Third Quarter 2026 Earnings Conference Call
- DuPont Announces Winners of Third Annual Tyvek® Sustainable Healthcare Packaging Awards
- DuPont Launches Sugar Separation Advisor to Accelerate Sugar and Sweetener Purification
- DuPont Launches Tyvek® with Renewable Attribution for Consumer & Industrial Applications
- DuPont de Nemours Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- DuPont, Chemours and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina
- Director Macpherson Donald G was granted 237 shares, increasing direct ownership by 12% to 2,196 units (SEC Form 4)